Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials ASCO Guidelines provide recommendations with comprehensive ...

HRR mutations are commonly of germline origin, with several real world studies suggesting a 23-44% probability of an HRR ...

Germline testing can identify hereditary cancer, which leads to implications for family members, cascade testing for relatives, and starting surveillance and prevention measures: Genetic testing in ...

More evidence points to the benefits of germline genetic testing for patients with various cancers. Such testing can identify mutations that may warrant a change of treatment and allow trying a ...

Morbidity, Mortality, and Improvement Rounds: Overlooked Risk in Cancer Care: Failure of Medical Reconciliation Among 41 participants, 35 (85%) agreed to germline testing. The mean DCS score was ...

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today the launch of a new line of germline cancer predisposition testing services. The new ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

A landmark trial aiming to shape the future of prostate cancer screening in the UK has begun testing a group of men ...

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...